Search for a trial | Research with human participants

1 results

Cost-effectiveness of CYP2C19 genotype guided treatment with antipaletelet drugs in patients with ST-segment-elevation myocardial infarction undergoing immediate percutaneous coronary intervention with stent implantation: optimization of treatment.

Approved WMORecruitment stopped

To assess the efficacy, safety and cost-effectiveness of the CYP2C19 genotype guided antiplatelet treatment strategy, using clopidogrel or prasugrel/ticagrelor.